<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03840187</url>
  </required_header>
  <id_info>
    <org_study_id>0097-18-BRZ</org_study_id>
    <nct_id>NCT03840187</nct_id>
  </id_info>
  <brief_title>Correlation Between Colposcopist Findings and Digital Cervicography Employing Gynescope System</brief_title>
  <official_title>Correlation Between Colposcopist Findings and Digital Cervicography Employing Gynescope System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barzilai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barzilai Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Correlation between colposcopist findings and digital cervicography employing Gynescope
      system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 30 women that will be referred for colposcopy examination at the standard indications
      will also undergo a colposcopy examination of the cervix by a gynescope. The physicain
      performing the optical test will record the findings in accordance with the International
      Federation for Cervical Pathology and Colposcopy (IFCPC) terminology. Categorical variable
      will be included in every record. At later stage, the images obtained by the cervicography
      will be evaluated and recorded in accordance with the IFCPC terminology. Correlation between
      the categorical findings in both assesments will be compared. The correlation measure will be
      performed by Kappa test according to the categorial result of both measurements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 11, 2019</start_date>
  <completion_date type="Actual">January 15, 2020</completion_date>
  <primary_completion_date type="Actual">January 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Categorical findings according in accordance with the International Federation of Cervical Pathology Colposcopy</measure>
    <time_frame>5 months</time_frame>
    <description>leukoplakia, aceto - white change, mosaic, punctuation, and abnormal vessels</description>
  </primary_outcome>
  <enrollment type="Actual">29</enrollment>
  <condition>Cervical Dysplasia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Digital cervicography</intervention_name>
    <description>Colposcopist findings and digital cervicography employing Gynescope system</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients reffered for colposcopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients reffered for colposcopy

        Exclusion Criteria:

        Patient refusion
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ofer Gemer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barzilai University Medical Center Ashkelon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barzilay University Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>January 15, 2020</last_update_submitted>
  <last_update_submitted_qc>January 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>digital cervicography</keyword>
  <keyword>Gynescope system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

